Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  fenretinide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 36 for your search:
Start Over
Phase III Randomized Study of Adjuvant Tamoxifen/Fenretinide vs Tamoxifen/Placebo in Postmenopausal Women with Receptor-Positive Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: postmenopausal
Sponsor: NCI
Protocol IDs: E-EB193, CLB-9443, NCCTG-953052, SWOG-9514, INT-0151, NCT00002646
Fenretinide in Treating Patients With Cervical Neoplasia
Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ID92-027, P30CA016672, MDA-ID-92027, NCI-P97-0092, CDR0000065761, NCT00003075
Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067387, MDA-ID-95236, NCI-G99-1621, NCI-T98-0051, ID95-236, T98-0051, NCT00004154
Phase I/II Study of Chemopreventive Agents for the Prevention of Skin Cancer (Summary Last Modified 04/1999)
Phase: Phase II, Phase I
Type: Prevention
Status: Completed
Age: 50-84
Sponsor: NCI
Protocol IDs: MDA-ID-95184, NCI-P97-0099
Phase I/II Pilot Study of Tamoxifen plus the Vitamin A Analogue Fenretinide in Patients with Metastatic Adenocarcinoma of the Breast
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: ICC-88B3, NCI-T89-0087D, T89-0087
Phase IIB Randomized, Double-Blind Chemoprevention Study of Fenretinide vs Placebo in Patients with Resected Transitional Cell Carcinoma of the Bladder at High Risk of Recurrence
Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9460, NCI-P96-0074
Phase II Study of Fenretinide (4-Hydroxyphenyl Retinamide; 4-HPR) in Oral Dysplastic Leukoplakia and Oral Dysplasia (Summary Last Modified 08/98)
Phase: Phase II
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: MSGCC-9224, NCI-P97-0098
Phase II Study of Fenretinide Prior to Prostatectomy for Prostate Cancer (Summary Last Modified 01/99)
Phase: Phase II
Type: Prevention
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: UAB-9431, NCI-P97-0103
Phase II Study of Fenretinide versus Finasteride versus Placebo in Patients with Localized Prostate Cancer (Summary Last Modified 11/97)
Phase: Phase II
Type: Prevention
Status: Closed
Age: 40 to 75
Sponsor: NCI
Protocol IDs: BCM-H2533, NCI-P97-0107
Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer
Phase: Phase II
Type: Prevention
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: ID94-029, P30CA016672, MDA-ID-94029, NCI-P97-0113, CDR0000065829, NCT00003099
Phase II Trial of Fenretinide in Patients With Skin Actinic Keratosis (Summary Last Modified 05/98)
Phase: Phase II
Type: Prevention
Status: Closed
Age: 45 and over
Sponsor: NCI
Protocol IDs: MSGCC-9215, NCI-P97-0114
Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome
Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066674, E-2695, UPCC-2600, NCI-P98-0134, NCT00003601
Fenretinide in Treating Patients With Leukoplakia of the Mouth
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067401, UAB-9713, NCI-G99-1626, NCT00004161
Fenretinide in Treating Patients With Recurrent Malignant Glioma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068068, NABTC-9905, UCLA-0006094, NCT00006080
Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ID99-334, U01CA070172, P30CA016672, MDA-ID-99334, NCI-610, CDR0000068294, 610, NCT00006471
Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000068428, CCUM-9940, NCI-T99-0112, T99-0112, NCT00009971
Chemotherapy in Treating Patients With Advanced Kidney Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068465, U01CA062487, P30CA022453, WSU-C-2232, NCI-WSU-910, NCT00011973
Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00457, PHII-25, N01CM17101, CDR0000068985, CCC-PHII-25, LAC-USC-5GYN003, NCI-19, 19, NCT00026091
Phase II Study of TMX plus Fenretinide for Metastatic Breast Cancer (Summary Last Modified 11/94)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-92-C-0231D, NCI-MB-299, NCI-T92-0082N, T92-0082
Phase II Trial of Fenretinide in Patients with Chemotherapy-Refractory Bladder Tumors (Summary Last Modified 12/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-92037, NCI-T92-0113C, T92-0113
Phase II Chemoprevention Study of Oral Fenretinide in Patients at Risk for Adenocarcinoma of the Prostate (Summary Last Modified 03/93)
Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: WSU-C-1001, NCI-P93-0035
Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and under at original diagnosis
Sponsor: NCI
Protocol IDs: NCI-2012-01802, COG-ADVL0024, COG-A0996, CDR0000269408, COG-ANBL0321, ADVL0024, ANBL0321, U10CA098543, NCT00053326
Phase II Randomized Study of Tamoxifen and Fenretinide for the Prevention of Breast Cancer
Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: CNR-IEO-007, U01-CA77188-01
Start Over